SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 11.06 |
| Enterprise Value ($M) | 11.97 |
| Book Value ($M) | -14.57 |
| Book Value / Share | -0.17 |
| Price / Book | -1.34 |
| NCAV ($M) | -20.04 |
| NCAV / Share | -0.41 |
| Price / NCAV | -0.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -3.54 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.13 |
| Current Ratio | 0.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.94 |
| Assets | 7.41 |
| Liabilities | 21.98 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -28.99 |
| Net Income | -29.22 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -26.98 |
| Cash from Investing | -0.48 |
| Cash from Financing | 29.04 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | First Light Acquisition Group, LLC | 1.00 | -86.66 | |
| 13G/A | Woodline Partners LP | 0.40 | -68.75 | |
| 13G/A | Vivaldi Asset Management, LLC | 0.00 | -100.00 | |
| 13G/A | Polar Asset Management Partners Inc. | 6.10 | 454.77 | |
| 13G/A | Spring Creek Capital Llc | 0.00 | -100.00 | |
| 13G/A | Hudson Bay Capital Management LP | 0.00 | -100.00 | |
| 13D/A | Jackson Investment Group, LLC | 9.10 | 0.00 | |
| 13D | Leftwich Scott | 9.20 | ||
| 13D | Camaisa Allan | 30.90 | ||
| 13G | Meteora Capital, LLC | 14.85 | ||
| 13G | Funicular Funds, LP | 17.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 34,770 | 143,364 | 24.25 | |
| 71,961 | 278,958 | 25.80 | |
| 45,868 | 370,111 | 12.39 | |
| 92,133 | 361,966 | 25.45 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ARMP – Armata Pharmaceuticals, Inc. | ATNM – Actinium Pharmaceuticals, Inc. |
| AZTR – Azitra, Inc. | CPHI – China Pharma Holdings, Inc. |
| CVM – CEL-SCI Corporation |
Financial data and stock pages provided by
Fintel.io